Improved VMAT planning for head and neck tumors with an advanced optimization algorithm
In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients.
Autor*in: |
Klippel, Norbert [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2015 |
---|
Schlagwörter: |
---|
Umfang: |
8 |
---|
Übergeordnetes Werk: |
Enthalten in: NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity - Sharfe, Nigel ELSEVIER, 2022, offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:25 ; year:2015 ; number:4 ; pages:333-340 ; extent:8 |
Links: |
---|
DOI / URN: |
10.1016/j.zemedi.2015.05.002 |
---|
Katalog-ID: |
ELV039813681 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV039813681 | ||
003 | DE-627 | ||
005 | 20230624064500.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2015 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.zemedi.2015.05.002 |2 doi | |
028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica |
035 | |a (DE-627)ELV039813681 | ||
035 | |a (ELSEVIER)S0939-3889(15)00057-4 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.45 |2 bkl | ||
100 | 1 | |a Klippel, Norbert |e verfasserin |4 aut | |
245 | 1 | 0 | |a Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
264 | 1 | |c 2015 | |
300 | |a 8 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. | ||
650 | 7 | |a Head and neck tumors |2 Elsevier | |
650 | 7 | |a VMAT |2 Elsevier | |
650 | 7 | |a Radiation oncology |2 Elsevier | |
650 | 7 | |a Therapy planning |2 Elsevier | |
700 | 1 | |a Schmücking, Michael |4 oth | |
700 | 1 | |a Terribilini, Dario |4 oth | |
700 | 1 | |a Geretschläger, Andreas |4 oth | |
700 | 1 | |a Aebersold, Daniel M. |4 oth | |
700 | 1 | |a Manser, Peter |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a Sharfe, Nigel ELSEVIER |t NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |d 2022 |d offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik |g Amsterdam [u.a.] |w (DE-627)ELV010493735 |
773 | 1 | 8 | |g volume:25 |g year:2015 |g number:4 |g pages:333-340 |g extent:8 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.zemedi.2015.05.002 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
936 | b | k | |a 44.45 |j Immunologie |q VZ |
951 | |a AR | ||
952 | |d 25 |j 2015 |e 4 |h 333-340 |g 8 |
author_variant |
n k nk |
---|---|
matchkey_str |
klippelnorbertschmckingmichaelterribilin:2015----:mrvdmtlnigohaadekuosihndacd |
hierarchy_sort_str |
2015 |
bklnumber |
44.45 |
publishDate |
2015 |
allfields |
10.1016/j.zemedi.2015.05.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica (DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Klippel, Norbert verfasserin aut Improved VMAT planning for head and neck tumors with an advanced optimization algorithm 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier Schmücking, Michael oth Terribilini, Dario oth Geretschläger, Andreas oth Aebersold, Daniel M. oth Manser, Peter oth Enthalten in Elsevier Sharfe, Nigel ELSEVIER NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity 2022 offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik Amsterdam [u.a.] (DE-627)ELV010493735 volume:25 year:2015 number:4 pages:333-340 extent:8 https://doi.org/10.1016/j.zemedi.2015.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.45 Immunologie VZ AR 25 2015 4 333-340 8 |
spelling |
10.1016/j.zemedi.2015.05.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica (DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Klippel, Norbert verfasserin aut Improved VMAT planning for head and neck tumors with an advanced optimization algorithm 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier Schmücking, Michael oth Terribilini, Dario oth Geretschläger, Andreas oth Aebersold, Daniel M. oth Manser, Peter oth Enthalten in Elsevier Sharfe, Nigel ELSEVIER NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity 2022 offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik Amsterdam [u.a.] (DE-627)ELV010493735 volume:25 year:2015 number:4 pages:333-340 extent:8 https://doi.org/10.1016/j.zemedi.2015.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.45 Immunologie VZ AR 25 2015 4 333-340 8 |
allfields_unstemmed |
10.1016/j.zemedi.2015.05.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica (DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Klippel, Norbert verfasserin aut Improved VMAT planning for head and neck tumors with an advanced optimization algorithm 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier Schmücking, Michael oth Terribilini, Dario oth Geretschläger, Andreas oth Aebersold, Daniel M. oth Manser, Peter oth Enthalten in Elsevier Sharfe, Nigel ELSEVIER NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity 2022 offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik Amsterdam [u.a.] (DE-627)ELV010493735 volume:25 year:2015 number:4 pages:333-340 extent:8 https://doi.org/10.1016/j.zemedi.2015.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.45 Immunologie VZ AR 25 2015 4 333-340 8 |
allfieldsGer |
10.1016/j.zemedi.2015.05.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica (DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Klippel, Norbert verfasserin aut Improved VMAT planning for head and neck tumors with an advanced optimization algorithm 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier Schmücking, Michael oth Terribilini, Dario oth Geretschläger, Andreas oth Aebersold, Daniel M. oth Manser, Peter oth Enthalten in Elsevier Sharfe, Nigel ELSEVIER NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity 2022 offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik Amsterdam [u.a.] (DE-627)ELV010493735 volume:25 year:2015 number:4 pages:333-340 extent:8 https://doi.org/10.1016/j.zemedi.2015.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.45 Immunologie VZ AR 25 2015 4 333-340 8 |
allfieldsSound |
10.1016/j.zemedi.2015.05.002 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica (DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 DE-627 ger DE-627 rakwb eng 610 VZ 44.45 bkl Klippel, Norbert verfasserin aut Improved VMAT planning for head and neck tumors with an advanced optimization algorithm 2015 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier Schmücking, Michael oth Terribilini, Dario oth Geretschläger, Andreas oth Aebersold, Daniel M. oth Manser, Peter oth Enthalten in Elsevier Sharfe, Nigel ELSEVIER NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity 2022 offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik Amsterdam [u.a.] (DE-627)ELV010493735 volume:25 year:2015 number:4 pages:333-340 extent:8 https://doi.org/10.1016/j.zemedi.2015.05.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.45 Immunologie VZ AR 25 2015 4 333-340 8 |
language |
English |
source |
Enthalten in NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity Amsterdam [u.a.] volume:25 year:2015 number:4 pages:333-340 extent:8 |
sourceStr |
Enthalten in NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity Amsterdam [u.a.] volume:25 year:2015 number:4 pages:333-340 extent:8 |
format_phy_str_mv |
Article |
bklname |
Immunologie |
institution |
findex.gbv.de |
topic_facet |
Head and neck tumors VMAT Radiation oncology Therapy planning |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |
authorswithroles_txt_mv |
Klippel, Norbert @@aut@@ Schmücking, Michael @@oth@@ Terribilini, Dario @@oth@@ Geretschläger, Andreas @@oth@@ Aebersold, Daniel M. @@oth@@ Manser, Peter @@oth@@ |
publishDateDaySort_date |
2015-01-01T00:00:00Z |
hierarchy_top_id |
ELV010493735 |
dewey-sort |
3610 |
id |
ELV039813681 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039813681</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624064500.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.zemedi.2015.05.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039813681</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0939-3889(15)00057-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Klippel, Norbert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improved VMAT planning for head and neck tumors with an advanced optimization algorithm</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck tumors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VMAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiation oncology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapy planning</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmücking, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Terribilini, Dario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geretschläger, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aebersold, Daniel M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manser, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Sharfe, Nigel ELSEVIER</subfield><subfield code="t">NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity</subfield><subfield code="d">2022</subfield><subfield code="d">offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010493735</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:333-340</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.zemedi.2015.05.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">333-340</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
author |
Klippel, Norbert |
spellingShingle |
Klippel, Norbert ddc 610 bkl 44.45 Elsevier Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
authorStr |
Klippel, Norbert |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV010493735 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 VZ 44.45 bkl Improved VMAT planning for head and neck tumors with an advanced optimization algorithm Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning Elsevier |
topic |
ddc 610 bkl 44.45 Elsevier Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning |
topic_unstemmed |
ddc 610 bkl 44.45 Elsevier Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning |
topic_browse |
ddc 610 bkl 44.45 Elsevier Head and neck tumors Elsevier VMAT Elsevier Radiation oncology Elsevier Therapy planning |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m s ms d t dt a g ag d m a dm dma p m pm |
hierarchy_parent_title |
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |
hierarchy_parent_id |
ELV010493735 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV010493735 |
title |
Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
ctrlnum |
(DE-627)ELV039813681 (ELSEVIER)S0939-3889(15)00057-4 |
title_full |
Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
author_sort |
Klippel, Norbert |
journal |
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |
journalStr |
NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2015 |
contenttype_str_mv |
zzz |
container_start_page |
333 |
author_browse |
Klippel, Norbert |
container_volume |
25 |
physical |
8 |
class |
610 VZ 44.45 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Klippel, Norbert |
doi_str_mv |
10.1016/j.zemedi.2015.05.002 |
dewey-full |
610 |
title_sort |
improved vmat planning for head and neck tumors with an advanced optimization algorithm |
title_auth |
Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
abstract |
In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. |
abstractGer |
In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. |
abstract_unstemmed |
In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
container_issue |
4 |
title_short |
Improved VMAT planning for head and neck tumors with an advanced optimization algorithm |
url |
https://doi.org/10.1016/j.zemedi.2015.05.002 |
remote_bool |
true |
author2 |
Schmücking, Michael Terribilini, Dario Geretschläger, Andreas Aebersold, Daniel M. Manser, Peter |
author2Str |
Schmücking, Michael Terribilini, Dario Geretschläger, Andreas Aebersold, Daniel M. Manser, Peter |
ppnlink |
ELV010493735 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
doi_str |
10.1016/j.zemedi.2015.05.002 |
up_date |
2024-07-06T21:33:40.311Z |
_version_ |
1803866991821324288 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV039813681</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624064500.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2015 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.zemedi.2015.05.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000000948.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV039813681</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0939-3889(15)00057-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.45</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Klippel, Norbert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Improved VMAT planning for head and neck tumors with an advanced optimization algorithm</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">In this study, the “Progressive Resolution Optimizer PRO3“ (Varian Medical Systems) is compared to the previous version „PRO2“ with respect to its potential to improve dose sparing to the organs at risk (OAR) and dose coverage of the PTV for head and neck cancer patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Head and neck tumors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VMAT</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Radiation oncology</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapy planning</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schmücking, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Terribilini, Dario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Geretschläger, Andreas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aebersold, Daniel M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Manser, Peter</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Sharfe, Nigel ELSEVIER</subfield><subfield code="t">NFκB pathway dysregulation due to reduced RelB expression leads to severe autoimmune disorders and declining immunity</subfield><subfield code="d">2022</subfield><subfield code="d">offizielles Organ der Deutschen, Österreichischen und Schweizerischen Gesellschaft für Medizinische Physik</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV010493735</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:25</subfield><subfield code="g">year:2015</subfield><subfield code="g">number:4</subfield><subfield code="g">pages:333-340</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.zemedi.2015.05.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.45</subfield><subfield code="j">Immunologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">25</subfield><subfield code="j">2015</subfield><subfield code="e">4</subfield><subfield code="h">333-340</subfield><subfield code="g">8</subfield></datafield></record></collection>
|
score |
7.400588 |